Kit for simultaneously detecting neisseria gonorrhoeae, chlamydia trachomatis and ureaplasma urealyticum nucleic acid, and application of kit
A technology for Neisseria gonorrhoeae and Chlamydia trachomatis, which is applied in the field of biological detection and can solve problems such as easy pollution
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0097] [Example 1] Sensitivity Test
[0098] Neisseria gonorrhoeae, Chlamydia trachomatis and Ureaplasma urealyticum nucleic acid detection kit can specifically detect Neisseria gonorrhoeae, Chlamydia trachomatis and Ureaplasma urealyticum, the common serum of Neisseria gonorrhoeae and Chlamydia trachomatis was selected in this study Type F, common serotype 3 of Ureaplasma urealyticum, the minimum detection limit was determined. See the table below for information:
[0099] Table 1 NG pathogen information
[0100] Pathogen name Bacterial Strains (ATCC) Corresponding unit NG 19424 >10 6 cfu / mL
CT-F VR-346 1.8×10 6 IFU / mL
UU 27815 10 7 CCU / vial
[0101] Each gradient virus dilution was repeated 3 to 5 times, and each copy was repeated 20 times. The virus level with a positive detection rate of 90% to 95% was used as the minimum detection limit. The detection results were as follows:
[0102] NG minimum detection limit det...
Embodiment 2
[0122] [Example 2] Specificity Verification
[0123] 1. Test Strains
[0124] After extracting nucleic acids from different microorganisms, they are tested to verify the specificity of the design of the primers and probes of the kit of the present invention. Relevant pathogens and titers are as follows:
[0125] Table 5 Specificity verification test strain information
[0126] microorganism concentration Mycoplasma hominis 1.0×10 7 CCU / mL
Mycoplasma genitalium 1.0×10 7 CCU / mL
Herpes simplex virus type I 1.0×10 6 TCID50 / mL
Herpes simplex virus type II 1.0×10 6 TCID50 / mL
Cytomegalovirus 1.0×10 6 TCID50 / mL
papillomavirus type 18 1.0×10 6 copies / mL
Candida albicans 2.8×10 6 TCID50 / mL
Hepatitis A virus 3.2×10 9 TCID50 / mL
Hepatitis B virus 8.89×10 8 TCID50 / mL
Staphylococcus aureus (24~40)×10 8 cfu / mL
Escherichia coli (12~14)×10 8 cfu / mL
[0127] ...
Embodiment 3
[0134] [Example 3] Verification of samples
[0135] 1. Clinical sample information
[0136] The tests came from a total of 320 samples from Wuhan First Hospital, including 189 male samples and 131 female samples, accounting for 59.06% and 40.94% respectively. Among the 452 samples, the oldest patient was 67 years old, the youngest was 16 years old, the average age was 31.25 years old, the standard deviation was 33.5 years old, and the median was 29 years old. The diagnosis results of the enrolled patients were all related to reproductive tract infection.
[0137] 2. Test results
[0138] (1) Neisseria gonorrhoeae test results
[0139] During the detection, the test kit of the present invention and a certain commercialized detection Neisseria gonorrhoeae fluorescent quantitative PCR kit were used to detect the samples simultaneously, and the detection results were summarized into four tables, as follows:
[0140]
[0141] For the 5 inconsistent samples, the "gene sequenci...
PUM
![No PUM](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/noPUMSmall.5c5f49c7.png)
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap